Genetic diversity within Mycobacterium tuberculosis complex impacts on the accuracy of genotypic pyrazinamide drug-susceptibility assay

Genetic diversity within Mycobacterium tuberculosis complex impacts on the accuracy of genotypic pyrazinamide drug-susceptibility assay

Bibliographic Details
Main Authors:	Köser, Claudio U., Comas, Iñaki, Feuerriegel, Silke, Niemann, Stefan, Gagneux, Sebastien, Peacock, Sharon J.
Format:	Online
Language:	English
Published:	Churchill Livingstone 2014
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4075347/

Similar Items

Comment on: Characterization of the embB gene in Mycobacterium tuberculosis isolates from Barcelona and rapid detection of main mutations related to ethambutol resistance using a low-density DNA array
by: Köser, Claudio U., et al.
Published: (2014)

Mycobacterium tuberculosis Pyrazinamide Resistance Determinants: a Multicenter Study
by: Miotto, Paolo, et al.
Published: (2014)

Evaluation of Customised Lineage-Specific Sets of MIRU-VNTR Loci for Genotyping Mycobacterium tuberculosis Complex Isolates in Ghana
by: Asante-Poku, Adwoa, et al.
Published: (2014)

Mapping of Genotype–Phenotype Diversity among Clinical Isolates of Mycobacterium tuberculosis by Sequence-Based Transcriptional Profiling
by: Rose, Graham, et al.
Published: (2013)

Host Targeted Activity of Pyrazinamide in Mycobacterium tuberculosis Infection
by: Manca, Claudia, et al.
Published: (2013)

Activity of 5-chloro-pyrazinamide in mice infected with Mycobacterium tuberculosis or Mycobacterium bovis
by: Ahmad, Zahoor, et al.
Published: (2012)

Mechanistic analysis elucidating the relationship between Lys96 mutation in Mycobacterium tuberculosis pyrazinamidase enzyme and pyrazinamide susceptibility
by: Vats, Chakshu, et al.
Published: (2015)

Direct Susceptibility Testing of Mycobacterium tuberculosis for Pyrazinamide by Use of the Bactec MGIT 960 System
by: Demers, Anne-Marie, et al.
Published: (2016)

Characterization of pncA mutations of pyrazinamide-resistant Mycobacterium tuberculosis in Korea.
by: Lee, K. W., et al.
Published: (2001)

The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis
by: Somoskovi, Akos, et al.
Published: (2001)

Pyrazinamide Resistance, Mycobacterium tuberculosis Lineage and Treatment Outcomes in San Francisco, California
by: Budzik, Jonathan M., et al.
Published: (2014)

PncAgene expression and prediction factors on pyrazinamide resistance in Mycobacterium tuberculosis
by: Untiveros, Katherine Lozano, et al.
Published: (2014)

Aspartate decarboxylase (PanD) as a new target of pyrazinamide in Mycobacterium tuberculosis
by: Shi, Wanliang, et al.
Published: (2014)

PYRAZINAMIDE-INDUCED MACULOPAPULAR RASH
by: Khayyam, Khalid Umer, et al.
Published: (2010)

The pyrazinamide susceptibility breakpoint above which combination therapy fails
by: Gumbo, Tawanda, et al.
Published: (2014)

Evolutionary forces in Mycobacterium tuberculosis: implications for product development
by: Gagneux, Sebastien
Published: (2010)

High Resolution Discrimination of Clinical Mycobacterium tuberculosis Complex Strains Based on Single Nucleotide Polymorphisms
by: Homolka, Susanne, et al.
Published: (2012)

Sequence analysis for detection of first-line drug resistance in Mycobacterium tuberculosis strains from a high-incidence setting
by: Feuerriegel, Silke, et al.
Published: (2012)

Within Host Evolution Selects for a Dominant Genotype of Mycobacterium tuberculosis while T Cells Increase Pathogen Genetic Diversity
by: Copin, Richard, et al.
Published: (2016)

PYRAZINAMIDE INDUCED ACUTE GOUTY ARTHRITIS
by: U N Pathak, et al.
Published: (2003-01-01)

Co-evolution of Mycobacterium tuberculosis and Homo sapiens
by: Brites, Daniela, et al.
Published: (2015)

A single-nucleotide-polymorphism real-time PCR assay for genotyping of Mycobacterium tuberculosis complex in peri-urban Kampala
by: Wampande, Eddie M., et al.
Published: (2015)

Novel Mycobacterium tuberculosis Complex Isolate from a Wild Chimpanzee
by: Coscolla, Mireia, et al.
Published: (2013)

Population-based resistance of Mycobacterium tuberculosis isolates to pyrazinamide and fluoroquinolones: results from a multicountry surveillance project
by: Zignol, Matteo, et al.
Published: (2016)

Whole-genome sequencing of rifampicin-resistant M. tuberculosis strains identifies compensatory mutations in RNA polymerase
by: Comas, Iñaki, et al.
Published: (2011)

Enhancement of cyclophosphamide cytotoxicity in vivo by the benzamide analogue pyrazinamide.
by: Horsman, M. R., et al.
Published: (1994)

A case of thrombocytopenia caused by rifampicin and pyrazinamide
by: Bansal, Rekha, et al.
Published: (2013)

Should pyrazinamide be preferred in tuberculosis treatment during pregnancy?
by: Karabay, Oguz, et al.
Published: (2013)

Optimization of SABRE for polarization of the tuberculosis drugs pyrazinamide and isoniazid
by: Zeng, Haifeng, et al.
Published: (2013)

Pharmacokinetics of isoniazid, rifampicin, pyrazinamide and ethambutol in Indian children
by: Mukherjee, Aparna, et al.
Published: (2015)

Revisiting Anti-tuberculosis Activity of Pyrazinamide in Mice
by: Almeida, Deepak V., et al.
Published: (2014)

Serial counts of Mycobacterium tuberculosis in sputum as surrogate markers of the sterilising activity of rifampicin and pyrazinamide in treating pulmonary tuberculosis
by: Brindle, Richard, et al.
Published: (2001)

Biochemical Characterization of Quinolinic Acid Phosphoribosyltransferase from Mycobacterium tuberculosis H37Rv and Inhibition of Its Activity by Pyrazinamide
by: Kim, Hyun, et al.
Published: (2014)

Mutations in panD encoding aspartate decarboxylase are associated with pyrazinamide resistance in Mycobacterium tuberculosis
by: Zhang, Shuo, et al.
Published: (2013)

A novel inexpensive electrochemical sensor for pyrazinoic acid as a potential tool for the identification of pyrazinamide-resistant Mycobacterium tuberculosis
by: Daniel Rueda, et al.
Published: (2018-01-01)

The effect of growth rate on pyrazinamide activity in Mycobacterium tuberculosis - insights for early bactericidal activity?
by: Pullan, Steven T., et al.
Published: (2016)

Draft Genome Sequences of Two Pyrazinamide-Resistant Clinical Isolates, Mycobacterium tuberculosis 13-4152 and 13-2459
by: Maslov, D. A., et al.
Published: (2015)

Whole-genome sequencing to control antimicrobial resistance
by: Köser, Claudio U., et al.
Published: (2014)

Two New Rapid SNP-Typing Methods for Classifying Mycobacterium tuberculosis Complex into the Main Phylogenetic Lineages
by: Stucki, David, et al.
Published: (2012)

Multidrug-resistant tuberculosis outbreak in an Italian prison: tolerance of pyrazinamide plus levofloxacin prophylaxis and serial interferon gamma release assays
by: Bedini, A., et al.
Published: (2016)